Thyrocare Technologies hits 52-week high, surges 28% in two days

The company’s normalized Ebitda grew 19 per cent year on year (YoY) at Rs 42.5 crore, while margins improved to 40 per cent compared with 37 per cent clocked in the previous year quarter